Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study.

Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blanchard DK, Fisher RE, Chiang SB, Elledge R, Mawad ME.

Radiology. 2008 Mar;246(3):734-41. doi: 10.1148/radiol.2463070962. Epub 2008 Jan 25.

2.

Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging.

Gilmore DM, Khullar OV, Jaklitsch MT, Chirieac LR, Frangioni JV, Colson YL.

J Thorac Cardiovasc Surg. 2013 Sep;146(3):562-70; discussion 569-70. doi: 10.1016/j.jtcvs.2013.04.010. Epub 2013 Jun 19.

3.

Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer.

Kitai T, Inomoto T, Miwa M, Shikayama T.

Breast Cancer. 2005;12(3):211-5.

4.

Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.

Inoue T, Nishi T, Nakano Y, Nishimae A, Sawai Y, Yamasaki M, Inaji H.

Breast Cancer. 2016 Mar;23(2):295-300. doi: 10.1007/s12282-014-0573-8. Epub 2014 Oct 28.

PMID:
25348937
5.

Near-infrared fluorescence sentinel lymph node detection in gastric cancer: A pilot study.

Tummers QR, Boogerd LS, de Steur WO, Verbeek FP, Boonstra MC, Handgraaf HJ, Frangioni JV, van de Velde CJ, Hartgrink HH, Vahrmeijer AL.

World J Gastroenterol. 2016 Apr 7;22(13):3644-51. doi: 10.3748/wjg.v22.i13.3644.

6.

Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green.

Aoyama K, Kamio T, Ohchi T, Nishizawa M, Kameoka S.

World J Surg Oncol. 2011 Dec 2;9:157. doi: 10.1186/1477-7819-9-157.

7.

The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping.

Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, Ngo L, Khamene A, Azar F, Frangioni JV.

Ann Surg Oncol. 2009 Oct;16(10):2943-52. doi: 10.1245/s10434-009-0594-2. Epub 2009 Jul 7.

8.

Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer.

Ogasawara Y, Ikeda H, Takahashi M, Kawasaki K, Doihara H.

World J Surg. 2008 Sep;32(9):1924-9. doi: 10.1007/s00268-008-9519-7.

PMID:
18330628
9.

Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.

van der Vorst JR, Schaafsma BE, Verbeek FP, Hutteman M, Mieog JS, Lowik CW, Liefers GJ, Frangioni JV, van de Velde CJ, Vahrmeijer AL.

Ann Surg Oncol. 2012 Dec;19(13):4104-11. doi: 10.1245/s10434-012-2466-4. Epub 2012 Jul 3.

10.

Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer.

Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, Liefers GJ, Choi HS, Gibbs-Strauss SL, Putter H, Gioux S, Kuppen PJ, Ashitate Y, Löwik CW, Smit VT, Oketokoun R, Ngo LH, van de Velde CJ, Frangioni JV, Vahrmeijer AL.

Ann Surg Oncol. 2011 Sep;18(9):2483-91. doi: 10.1245/s10434-011-1566-x. Epub 2011 Mar 1.

11.

The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study.

Ballardini B, Santoro L, Sangalli C, Gentilini O, Renne G, Lissidini G, Pagani GM, Toesca A, Blundo C, del Castillo A, Peradze N, Caldarella P, Veronesi P.

Eur J Surg Oncol. 2013 Dec;39(12):1332-6. doi: 10.1016/j.ejso.2013.10.004. Epub 2013 Oct 24.

PMID:
24184123
12.

Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer.

Takeuchi M, Sugie T, Abdelazeem K, Kato H, Shinkura N, Takada M, Yamashiro H, Ueno T, Toi M.

Breast J. 2012 Nov-Dec;18(6):535-41. doi: 10.1111/tbj.12004. Epub 2012 Sep 26.

PMID:
23009222
13.

Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.

Jung SY, Kim SK, Kim SW, Kwon Y, Lee ES, Kang HS, Ko KL, Shin KH, Lee KS, Park IH, Ro J, Jeong HJ, Joo J, Kang SH, Lee S.

Ann Surg Oncol. 2014 Apr;21(4):1254-9. doi: 10.1245/s10434-013-3437-0. Epub 2013 Dec 20.

PMID:
24356798
14.

Indocyanine green injection for detecting sentinel nodes using color fluorescence camera in the laparoscopy-assisted gastrectomy.

Yoshida M, Kubota K, Kuroda J, Ohta K, Nakamura T, Saito J, Kobayashi M, Sato T, Beck Y, Kitagawa Y, Kitajima M.

J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:29-33. doi: 10.1111/j.1440-1746.2012.07067.x.

PMID:
22486868
15.

Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience.

Hirche C, Dresel S, Krempien R, Hünerbein M.

Ann Surg Oncol. 2010 Sep;17(9):2357-62. doi: 10.1245/s10434-010-1010-7. Epub 2010 Mar 9.

PMID:
20217256
16.

Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer.

Hutteman M, van der Vorst JR, Gaarenstroom KN, Peters AA, Mieog JS, Schaafsma BE, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL.

Am J Obstet Gynecol. 2012 Jan;206(1):89.e1-5. doi: 10.1016/j.ajog.2011.07.039. Epub 2011 Jul 30.

17.

Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer.

Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, Frangioni JV, van de Velde CJ, van Leeuwen FW, Vahrmeijer AL.

Br J Surg. 2013 Jul;100(8):1037-44. doi: 10.1002/bjs.9159. Epub 2013 May 21.

18.

Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients.

van der Vorst JR, Schaafsma BE, Verbeek FP, Keereweer S, Jansen JC, van der Velden LA, Langeveld AP, Hutteman M, Löwik CW, van de Velde CJ, Frangioni JV, Vahrmeijer AL.

Oral Oncol. 2013 Jan;49(1):15-9. doi: 10.1016/j.oraloncology.2012.07.017. Epub 2012 Aug 28.

19.

Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.

Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK.

Clin Nucl Med. 2005 Jan;30(1):11-5.

PMID:
15604959
20.

Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients.

Motomura K, Komoike Y, Hasegawa Y, Kasugai T, Inaji H, Noguchi S, Koyama H.

J Surg Oncol. 2003 Feb;82(2):91-6; discussion 96-7.

PMID:
12561063

Supplemental Content

Support Center